×
验证码:
换一张
忘记密码?
记住我
×
统一认证登录
登录
中文版
|
English
上海科技大学知识管理系统
ShanghaiTech University Knowledge Management System
统一认证登录
登录
注册
ALL
ORCID
题名
作者
发表日期
关键词
文献类型
DOI
出处
存缴日期
收录类别
出版者
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
知识整合
学习讨论厅
反馈留言
个人主页
个人信息
个人简介
科研成果
期刊论文(24)
专利(2)
预印本(1)
来源
JOURNAL OF MEDICINAL CHEMI...(4)
RSC ADVANCES(3)
ADVANCED SYNTHESIS & CATAL...(2)
ANGEWANDTE CHEMIE-INTERNAT...(2)
MOLECULES(2)
ACS CATALYSIS(1)
收录类别
SCI(20)
SCIE(10)
IC(7)
EI(5)
CCR(3)
SCOPUS(2)
访问统计
来源
JOURNAL OF MEDICINAL CHEMI...(4)
RSC ADVANCES(3)
ADVANCED SYNTHESIS & CATAL...(2)
ANGEWANDTE CHEMIE-INTERNAT...(2)
MOLECULES(2)
ACS CATALYSIS(1)
ACTA PHARMACEUTICA SINICA ...(1)
CELL METABOLISM(1)
CHEMICAL REVIEWS(1)
CHINESE CHEMICAL LETTERS(1)
EUROPEAN JOURNAL OF MEDICI...(1)
NATURE(1)
NATURE COMMUNICATIONS;(1)
ORGANIC CHEMISTRY FRONTIER...(1)
ORGANIC LETTERS(1)
SIGNAL TRANSDUCTION AND TA...(1)
bioRxiv(1)
发表日期
2025(2)
2024(3)
2023(3)
2022(2)
2021(4)
2020(2)
2019(2)
2018(2)
2017(3)
2015(1)
2014(3)
关键词云
More»
成果统计
More»
×
知识图谱
合作作者[TOP 5]
点击查看合作网络
Wang, Jiang
合作成果数:9
Li, Chunpu
合作成果数:7
王宝
合作成果数:5
Zhou, Yu
合作成果数:5
Gao, Feng
合作成果数:4
合作作者
Wang, Jiang
合作成果数:9
Li, Chunpu
合作成果数:7
王宝
合作成果数:5
Zhou, Yu
合作成果数:5
Gao, Feng
合作成果数:4
Han, Xu
合作成果数:4
Hu, Shulei
合作成果数:4
白芳
合作成果数:3
张向磊
合作成果数:3
Luis Acena, Jose
合作成果数:3
Soloshonok, Vadim A.
合作成果数:3
丁健
合作成果数:2
丛湛青
合作成果数:2
董光玉
合作成果数:2
陈晓旭
合作成果数:2
冯明顺
合作成果数:2
任鹏璇
合作成果数:2
许叶春
合作成果数:2
张书睿
合作成果数:2
访问统计
总访问量
1422
访问来源
内部: 9
外部: 1413
国内: 1187
国外: 235
年访问量
219
访问来源
内部: 0
外部: 219
国内: 203
国外: 16
月访问量
31
访问来源
内部: 0
外部: 31
国内: 28
国外: 3
访问量
访问量
1.
Rh(III)-Catalyzed Annulation of Boc-Protected Benzamides with Diaz..
[29930]
2.
Sulfoximines-Assisted Rh(III)-Catalyzed C-H Activation and Intramo..
[2549]
3.
Ligand recognition mechanism of the human relaxin family peptide r..
[1547]
4.
Ni(ii)-catalyzed mono-selective ortho-arylation of unactivated ary..
[915]
5.
一种杂环化合物的应用
[904]
6.
一种三环类化合物、其制备方法及其应用
[828]
7.
Structures of human mGlu2 and mGlu7 homo- and heterodimers
[665]
8.
Ruthenium-Catalyzed Redox-Neutral [4+1] Annulation of Benzamides a..
[644]
9.
Discovery and Optimization of Novel, Selective Histone Methyltrans..
[576]
10.
Propargyl Alcohols as One-Carbon Synthons: Redox-Neutral Rhodium(I..
[574]
11.
A unique peptide recognition mechanism by the human relaxin family..
[546]
12.
Cobalt-catalyzed C(sp(3))-H/C(sp(2))-H oxidative coupling between ..
[545]
13.
Cp*Rh(III)-Catalyzed Directed C-H Methylation and Arylation of Qui..
[544]
14.
Discovery of novel ceramide analogs with favorable pharmacokinetic..
[532]
15.
Rational Design and Development of Novel CDK9 Inhibitors for the T..
[517]
16.
Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tu..
[513]
17.
Cobalt(iii)-catalyzed site-selective C-H amidation of pyridones an..
[475]
18.
Construction of Vinyl-Substituted N-Heterocycles via Rh(III)- Cata..
[419]
19.
Discovery, Optimization, and Evaluation of Novel Pyridin-2(1
H
[416]
20.
A removable directing group-assisted Rh(iii)-catalyzed direct C-H ..
[377]
21.
Rh(III)-catalyzed late-stage C-H alkenylation and macrolactamizati..
[331]
22.
Structure-based design of pan-coronavirus inhibitors targeting hos..
[329]
23.
Drug discovery targeting thyroid hormone receptor f3 (THRf3) for t..
[59]
24.
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis..
[27]
下载量
1.
Rh(III)-Catalyzed Annulation of Boc-Protected Benzamides with Diaz..
[28163]
2.
Sulfoximines-Assisted Rh(III)-Catalyzed C-H Activation and Intramo..
[1735]
3.
Ni(ii)-catalyzed mono-selective ortho-arylation of unactivated ary..
[280]
4.
Ligand recognition mechanism of the human relaxin family peptide r..
[260]
5.
A unique peptide recognition mechanism by the human relaxin family..
[99]
6.
Structure-based design of pan-coronavirus inhibitors targeting hos..
[18]
7.
Construction of Vinyl-Substituted N-Heterocycles via Rh(III)- Cata..
[9]
8.
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis..
[6]
9.
Discovery and Optimization of Novel, Selective Histone Methyltrans..
[2]
10.
Cobalt-catalyzed C(sp(3))-H/C(sp(2))-H oxidative coupling between ..
[2]
11.
Cobalt(iii)-catalyzed site-selective C-H amidation of pyridones an..
[2]
12.
Discovery, Optimization, and Evaluation of Novel Pyridin-2(1
H
[2]
13.
Drug discovery targeting thyroid hormone receptor f3 (THRf3) for t..
[2]
14.
Ruthenium-Catalyzed Redox-Neutral [4+1] Annulation of Benzamides a..
[1]
15.
Discovery of novel ceramide analogs with favorable pharmacokinetic..
[1]
16.
Structures of human mGlu2 and mGlu7 homo- and heterodimers
[1]
17.
一种杂环化合物的应用
[1]
18.
Rh(III)-catalyzed late-stage C-H alkenylation and macrolactamizati..
[1]
科研成果
27
46297
30585
4857
0
14
Items
Views
Downloads
TC[WOS]
TC[CSCD]
H-index
排序方式:
按发表日期降序
按发表日期升序
按WOS被引频次降序
按期刊影响因子降序
正在努力地加载数据中,请稍候……
[1]
Jie Jiang.,Yuqing Gao.,Jiang Wang.,Yan Huang.,Rong Yang.,...&Cen Xie.(2025).Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism.
CELL METABOLISM
,1-18.
浏览/下载:
27/6
; 被引[WOS]:
0
; IF:
27.7
/
31.2
评论
推荐
收藏
[2]
Wang, Kean,Chen, Feiyang,Wang, Jiang,&Liu, Hong.(2025).Drug discovery targeting thyroid hormone receptor f3 (THRf3) for the treatment of liver diseases and other medical indications.
ACTA PHARMACEUTICA SINICA B
,15(1).
浏览/下载:
59/2
; 被引[WOS]:
1
; IF:
14.7
/
14.1
评论
推荐
收藏
[3]
Hu, Shulei.,Zhang, Yu.,Xie, Xiong.,Li, Luhan.,Chen, Kaixian.,...&Wang, Jiang.(2024).Rh(III)-catalyzed late-stage C-H alkenylation and macrolactamization for the synthesis of cyclic peptides with unique Trp(C7)-alkene crosslinks.
CHINESE CHEMICAL LETTERS
,35(8).
浏览/下载:
331/1
; 被引[WOS]:
4
; IF:
9.4
/
7.3
评论
推荐
收藏
[4]
xiexiong.,Qiaoshuai Lan.,Jinyi Zhao.,Sulin Zhang.,Liu L.,...&Hong Liu.(2024).Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1..
SIGNAL TRANSDUCTION AND TARGETED THERAPY
,9,1651-1664.
浏览/下载:
329/18
; 被引[WOS]:
11
; IF:
40.8
/
40.5
评论
推荐
收藏
[5]
Xu, Zichao.,Peng, Xia.,Zhang, Renjie.,Ji, Yinchun.,You, Mengke.,...&Liu, Hong.(2024).Discovery, Optimization, and Evaluation of Novel Pyridin-2(1
H
)-one Analogues as Potent TRK Inhibitors for Cancer Treatment.
JOURNAL OF MEDICINAL CHEMISTRY
,67(2).
浏览/下载:
416/2
; 被引[WOS]:
2
; IF:
6.8
/
7.1
评论
推荐
收藏
[6]
Chen, Yan.,Zhou, Qingtong.,Wang, Jiang.,Xu, Youwei.,Wang, Yun.,...&Wang, Ming-Wei.(2023).Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4).
NATURE COMMUNICATIONS;
,14(1).
浏览/下载:
1547/260
; 被引[WOS]:
6
; IF:
14.7
/
16.1
评论
推荐
收藏
[7]
白芳,柳红,许叶春,等. 一种三环类化合物、其制备方法及其应用. 2023-01-03.
浏览/下载:
828/0
评论
推荐
收藏
[8]
Zhang, Shurui,Hu, Shulei,Wang, Kean,Yang, Zhao,Liu, Hong,&Wang, Jiang.(2023).Construction of Vinyl-Substituted N-Heterocycles via Rh(III)- Catalyzed C-H Functionalization/Annulation of Pyrazolidinones.
ADVANCED SYNTHESIS & CATALYSIS
.
浏览/下载:
419/9
; 被引[WOS]:
11
; IF:
4.4
/
4.6
评论
推荐
收藏
[9]
Chen, Y.,Zhou, Q.,Wang, J.,et al. A unique peptide recognition mechanism by the human relaxin family peptide receptor 4 (RXFP4). 2022.
浏览/下载:
546/99
; 被引[WOS]:
0
评论
推荐
收藏
[10]
Zhang, Shurui.,Chen, Xiaoxu.,Wu, Chenglin.,Xu, Hui.,Xie, Xiong.,...&Wang, Jiang.(2022).Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer.
JOURNAL OF MEDICINAL CHEMISTRY
,65(11).
浏览/下载:
513/0
; 被引[WOS]:
10
; IF:
6.8
/
7.1
评论
推荐
收藏
每页显示
10
0
条
‹
1
2
3
›